Pediatricians prescribe antibiotics about twice as often as they’re actually needed for children with ear and throat infections, a new study indicates.
The Hamilton-T1 transport ventilator is now approved in the EU with a neonatal option, according to the company.
“Tome Un Respiro” is a Spanish-language campaign to raise awareness among Hispanics in the US about the prevalence, treatment options, and disease management of COPD.
Philips Respironics has launched its new Philips Respironics Home Health Store to improve how homecare providers order products and solutions.
A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study presented at the European Respiratory Society’s International Congress.
A joint effort by National Jewish Health and Icahn School of Medicine at Mount Sinai, The Respiratory Institute will provide comprehensive care to patients in New York City while furthering national respiratory research, beginning October 1st.
An International Trade Commission judge ruled last week that 9 products from BMC Medical Co Ltd, a Chinese company, infringe on ResMed patents.
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily ICS for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older.
A new therapeutic drug, GAL-021, may reverse or prevent respiratory depression, or inadequate breathing, in patients taking opioid medication without compromising pain relief or increasing sedation.
AstraZeneca has launched a Phase III test of its targeted IL-13 asthma drug tralokinumab but will face heavyweight competition in the clinic from Roche.